| Intestinal permeation enhancers BJ Aungst Journal of pharmaceutical sciences 89 (4), 429-442, 2000 | 661 | 2000 |
| Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides BJ Aungst, NJ Rogers, E Shefter International journal of pharmaceutics 33 (1-3), 225-234, 1986 | 448 | 1986 |
| Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism BJ Aungst Journal of pharmaceutical sciences 82 (10), 979-987, 1993 | 436 | 1993 |
| Absorption enhancers: applications and advances BJ Aungst The AAPS journal 14 (1), 10-18, 2012 | 399 | 2012 |
| Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. BJ Aungst, NJ Rogers, E Shefter Journal of Pharmacology and Experimental Therapeutics 244 (1), 23-27, 1988 | 274 | 1988 |
| Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly … DJP Pinto, MJ Orwat, S Wang, JM Fevig, ML Quan, E Amparo, J Cacciola, ... Journal of medicinal chemistry 44 (4), 566-578, 2001 | 267 | 2001 |
| Site Dependence of Absorption-Promoting Actions of Laureth-9, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery BJ Aungst, NJ Rogers Pharmaceutical research 5, 305-308, 1988 | 235 | 1988 |
| Trandermal delivery of opioids B Aungst, RC DiLuccio US Patent 4,626,539, 1986 | 233 | 1986 |
| Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants BJ Aungst Pharmaceutical research 6, 244-247, 1989 | 225 | 1989 |
| Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine H Saitoh, BJ Aungst Pharmaceutical research 12, 1304-1310, 1995 | 197 | 1995 |
| Enhancement of the intestinal absorption of peptides and nonpeptides BJ Aungst, H Saitoh, DL Burcham, SM Huang, SA Mousa, MA Hussain Journal of controlled release 41 (1-2), 19-31, 1996 | 193 | 1996 |
| Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery BJ Aungst, NJ Rogers International journal of pharmaceutics 53 (3), 227-235, 1989 | 183 | 1989 |
| Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and … BJ Aungst, JA Blake, MA Hussain Pharmaceutical research 7, 712-718, 1990 | 177 | 1990 |
| Optimizing oral bioavailability in drug discovery: an overview of design and testing strategies and formulation options BJ Aungst Journal of pharmaceutical sciences 106 (4), 921-929, 2017 | 146 | 2017 |
| Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration BJ Aungst, MA Hussain US Patent 4,673,679, 1987 | 128 | 1987 |
| P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs BJ Aungst Advanced drug delivery reviews 39 (1-3), 105-116, 1999 | 116 | 1999 |
| Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs MA Hussain, BJ Aungst, CA Koval, E Shefter Pharmaceutical research 5, 615-618, 1988 | 111 | 1988 |
| The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds BJ Aungst, NH Nguyen, JP Bulgarelli, K Oates-Lenz Pharmaceutical research 17, 1175-1180, 2000 | 107 | 2000 |
| Development and in vivo evaluation of buccal tablets prepared using danazol–sulfobutylether 7 β‐cyclodextrin (SBE 7) complexes AC Jain, BJ Aungst, MC Adeyeye Journal of pharmaceutical sciences 91 (7), 1659-1668, 2002 | 99 | 2002 |
| Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses BJ Aungst, NH Nguyen, NJ Rogers, SM Rowe, MA Hussain, SJ White, ... International Journal of Pharmaceutics 156 (1), 79-88, 1997 | 91 | 1997 |
Ho-Leung FungUniversity at BuffaloDirección de correo verificada de buffalo.edu